Introduction
The definition of the biologic roles of interferon y (IFNy) has been facilitated by the availability of purified recombinant IFNy and neutralizing IFNy-specific monoclonal antibodies (MAbs) (Farrar and Schreiber, 1993) . Recently, the generation of mice lacking either the IFNy or IFNy receptor genes has allowed for a broader appreciation of the in vivo functions of IFNy (Dalton et al., 1993; Huang et al., 1993) . However, since IFNy receptors are expressed on nearly all cells, the current technologies have been unable to define the cell-specific functions of this cytokine in vivo.
We have used dominant-negative mutant forms of the IFNy receptor a chain to elucidate the cell-specific actions of IFNy (Dighe et al., 1993 (Dighe et al., , 1994 . Overexpression of a cytoplasmically truncated form of the IFNr receptor a chain in homologous cells eliminated cellular responses to IFNr in vitro (Dighe et al., 1993) . When this technique was used with cultured murine fibroblasts, the resulting cells became IFNy unresponsive and failed to induce a variety of IFNy-dependent cellular responses in vitro. These included induction of IRF-1 gene transcription, expression of inducible nitric oxide (NO) synthase, up-regulation of major histocompatibility complex (MHC) class I protein expression, and induction of an antiviral response. More recently, we expressed dominant-negative IFNy receptors in a transplantable murine fibrosarcoma and used these cells to elucidate a novel role for IFNy in the develop ment of anti-tumor responses in mice (Dighe et al., 1994) . Using Meth A tumor cells that overexpressed a cytoplasmitally truncated IFNy receptor a chain, we showed that IFNy-insensitive Meth A cells displayed enhanced tumorigenicity compared with control Meth A cells and resisted rejection in endotoxin-treated and immune mice. In addition, IFNy-insensitive tumor cells were poorly immunogenic. These results demonstrated that IFNy has direct effects on tumor cell immunogenicity and thus plays an important role in promoting tumor cell recognition and elimination.
Although the two previous studies validated the use of dominant-negative IFNy receptors as a means of selectively eliminating the response of specific cell populations to IFNr, they required the use of transfected cultured cells. To explore whether tissue-specific IFNy unresponsiveness could be induced in intact animals, we generated transgenic mice in which adominant-negative IFNy receptor mutant was targeted to specific cell types using tissuespecific promoters. Herein, we document the generation and characterization of transgenic mice with targeted IFNy unresponsiveness in either the macrophage or Tcell compartment. Moreover, we demonstrate the functional consequences of cell-specific IFNy insensitivity and define the primary cellular targets of the actions of IFNr in the development of antimicrobial and allogeneic responses and identify one of the cell-specific actions of IFNy in facilitating development of CD4+ T helper (Th) cell subsets.
Results

Generation of Transgenic Mice Expressing a Dominant-Negative
Form of the IFNy Receptor a chain in Macrophages Based on the well-established role of IFNy in affecting macrophage function in vitro, we chose initially to target IFNy unresponsiveness to the macrophage compartment. We used a cDNA encoding a previously characterized cytoplasmically truncated dominant-negative form of the IFNy receptor a chain (Dighe et al., 1993) . To enhance transgene detection, the cDNA was modified at its 5' end to encode the myc protc-oncogene epitope recognized by the MAb 9ElO. This cDNA was placed under the control of the human lysozyme promoter for selective expression in macrophages.
FACS analysis of resident peritoneal macrophages derived from transgenic mice showed that the transgene was expressed at high levels on F4/80-positive cells (Figure 1 not show 9ElO staining, suggesting that transgene expression was limited to mature resident macrophages. Flow cytometric analysis of peripheral blood revealed low level 9ElO staining in a subset of the Mac-l+ cells (3%-6% of total) but not on T cells (CD3+), B cells (62207, neutrophils (Gr-1') or natural killer (NK) cells (5E6') (data not shown). In whole splenocyte populations, the epitopetagged receptor was detectable only on Mac-l+ cells, but at low levels. Identical patterns of expression were observed in three lines of mice derived from distinct founders. Normal numbers of CD3+, B220+, and NK cells were present in blood, thymus, and spleen in comparison to nontransgenic controls, demonstrating that no significant alteration of hematopoetic cell development had occurred secondary to transgene expression. Thus, the human lysozyme promoter-driven construct used in this study directed expression of the epitope-tagged truncated murine IFNr receptor a chain specifically to a subset of cells of the macrophage lineage. On day 5, bacteria in the spleens and livers of infected mice were quantitated by colony counts of homogenates plated on BHI agar. At this time, 33% of the transgenepositive mice had died (3 of 9) whereas none of the transgene-negative group had died (0 of 10). In mice treated with the anti-IFNr MAb H22, 44% (4 of 9) of the transgene-positive mice and 40% (4 of 10) of transgene-negative mice died by day 5.
rived from nontransgenic littermate control mice with the combination of IFNy and lipopolysaccharide (LPS)-induced expression of NO synthase (INOS), leading to the production of 5.4 nmol nitrite/105cells (Figure 2A ). In contrast, rPECs from the macrophage-targeted transgenic mice (hLP-myc-mgRAIC) cultured with the combination of IFNy and LPS produced only 0.3 nmol nitrite/lo5 cells, an amount that was comparable to the level of nitrite produced with LPS alone (0.2 nmol/105 cells). The lack of iNOS induction in rPECs from transgenic mice wasspecifitally due to IFNy unresponsiveness, since the cells responded to the combination of IFNa plus LPS in a manner that was comparable to rPECs isolated from littermate controls (4.1 and 5.4 nmolllo5 cells, respectively IFNy is required for the initiation of antimicrobial responses and its site of action is presumed to be the macrophage (Buchmeier and Schreiber, 1985; Bancroftet al., 1991) . To test this hypothesis formally, we infected transgene-positive or littermate control mice with 5 x lo5 colony-forming units (cfu) of Listeria. This dose of Listeria was sublethal for control mice(Oof lOdead byday5). Incontrast, 33%oftransgene-positive animals (3 of 9) died by day 5. Bacterial titers in the spleen and liver of transgene-positive mice were approximately lOO-fold greater than observed in control animals ( Figure 28 ). As expected, pretreatment of control mice with a neutralizing antibody to IFNy increased their susceptibility to Listeria (4 of 10 dead by day 5). Surviving antibody-treated control mice had Listeria titers lOO-fold higher than control mice. Anti-IFNy treatment of transgene-positive animals did not significantly alter lethality (4 of 9 dead)or bacterial titers. Thus, whole animal neutralization of IFNy produced similar effects to those seen by selectively inducing a state of IFNy unresponsiveness in the resident macrophage. These results suggest that the resident macrophage is the principal cell required to initiate an IFNy-dependent anti-Listeria response.
Form of the IFNy Receptor Selectively in T Cells Resolution of Listeria infection requires induction of cellmediated immunity that is dependent on the induction of the CD4+ Thl subset. IFNy has been suggested to regulate Th phenotype development at the level of the T cell (Gajewski and Fitch, 1988; Seder et al., 1993; Schmitt et al., 1994) . To examine this issue in more detail, we generated transgenic mice with selective IFNy unresponsiveness in T cells by driving the expression of the epitope-tagged dominant-negative IFNy receptor a chain with the Ickproximal promoter. Expression of the epitope-tagged, truncated IFNy receptor in T cell-targeted transgenic mice (Ick-myc-mgRAIC) was restricted to the T cell lineage. from these lines expressed high levels of the epitopetagged receptor (9ElO staining), as measured by flow cytometry ( Figure 3 ). The epitope-tagged receptor was also expressed at high levels in the spleen and thymus on virtually all CD3' cells (data not shown). Normal distributions of CD3+, CD4+, CD8+, B220+, and NK cells were seen in thymus, spleen, and peripheral blood compared with nontransgenic controls. These results demonstrated that the epitope-tagged dominant-negative form of the IFNy receptor was selectively targeted to the T cell lineage and did not effect either general hematopoietic or specific lymphocyte lineage development. 8220' populations, as detected by flow cytometry ( Figure  4 ). In contrast, CD3+ ceils from T cell-targeted transgenic mice did not increase MHC class I expression in response to murine IFNy. This loss of IFNy responsiveness was specific to the CD3+ population, since B220' cells from Ickmyc-mgRAIC transgenic mice remained fully responsive to IFNy. The lack of IFNy responses in the transgenic T cells was not due to a generalized defect in the MHC class I synthesis pathway, since both CD3+ and B22O'cells from transgene-positive and control mice showed enhanced MHC class I expression in response to IFNa (data not shown). Like peripheral blood leukocytes, splenocytes from transgenic mice also showed specific IFNy unresponsiveness that was restricted to the CD3+ population (data not shown). Peritoneal macrophages derived from the T cell-targeted transgenic mice showed normal induction of iN0.S in response to the combination of IFNr and LPS (data not shown). Thus, transgenic mice that express the dominant-negative form of the IFNy receptor under the control of the Ick proximal promoter show a selective state of functional unresponsiveness to IFNy, which localizes to the T cell compartment.
To assess the functional consequences of eliminating IFNy responses in T cells, we examined allogeneic T cell proliferative responses in splenocytes derived from T celltargeted transgenic and littermate control mice. Previous reports established that global elimination of cellular responses to IFNy in vitro (either using neutralizing MAbs or by targeted disruption of the IFNr gene) augmented the proliferative responses of T cells to allogeneic stimuli (Bucy et al., 1988; Dalton et al., 1993) . We therefore examined responses of splenocytes from our H-2d haplotype transgenic mice or controls to irradiated H-2b haplotype allogeneic stimulator cells ( Figure 5 ). Nontransgenic littermate control splenocytes proliferated when cultured with allogeneic stimulator cells. As expected, neutraliza- Proliferation was assessed by thymidine incorporation as described in Experimental Procedures.
Neutralization of IFNy was carried out by the addition of 100 uglml of the anti-IFNy MAb H22 at the initiation of the cultures.
tion of IFNy with the anti-IFNy MAb H22 increased the proliferative response of responding cells by 3-to 4-fold. In contrast, Tcellsfrom H-2d Ick-myc-mgRAIC transgenic mice displayed an increased proliferative response, comparable to that of the H2Btreated control cell cultures. No additional increase in proliferation of IFNy-unresponsive T cells occurred when IFNy was neutralized. This result thus demonstrates that the anti-proliferative action of IFNy in mixed lymphocyte reaction (MLR) cultures is the result of a direct effect of IFNy on T cells.
To assess the in vivo consequences of T cell-specific IFNy unresponsiveness on the development of antimicrobial responses, we infected T cell-targeted transgenepositive or littermate control mice with 5 x 1 O5 cfu of Listeria. None of the mice in either group died of the infection, indicating that both groups were capable of developing sterilizing anti-Listeria immunity (0 of 8 and 0 of 10 dead by day 5 for transgenic and control mice, respectively). Bacterial titers on day 5 in the spleen and liver of transgene-positive mice were similar to that of littermate control animals (data not shown). The ability of both groups of mice to produce sterilizing immunity to Listeria was demonstrated by the absence of Listeria cfu in the spleen and liver of the mice on day 10. As expected, pretreatment of transgene-positive or control mice with a neutralizing antibody to IFNr increased susceptibility to Listeria (4 of 8 transgene-positive and 4 of 10 control mice dead by day 5). Surviving H22-treated mice had Listeria titers lOO-fold higher than untreated transgene-positive or control mice (data not shown). Thus, in contrast with the results obtained using mice with targeted macrophage IFNy unresponsiveness, mice with targeted T cell IFNy unresponsiveness had no defect in the ability to mount a full curative anti-Listeria response. Since sterilizing immunity to Listeria is known to require development of a cell-mediated immune response, and since cell-mediated immunity is promoted by the Thl subset, our results suggest Thl subset induction occurs normally in transgenic mice with T cell-targeted IFNy responsiveness. (Murphy et al., 1990) . This system allows for experimental control over the antigen-presenting cell (APC), cytokine environment, and exposure to pathogens during primary T cell activation (Hsieh et al., 1992 (Hsieh et al., , 1993b . Using this system, IFNy has been found to be necessary but not sufficient for induction by heat-killed Listeria monocytogenes (HKLM) of a Thl phenotype (Hsieh et al., 1992 (Hsieh et al., , 1993a (Hsieh et al., , 1993b . Additionally, IFNy has been reported to exert a selective antiproliferative effect on Th2 and not Thl , thereby leading to the suggestion that IFNy may regulate Th phenotype development by inhibiting Th2 formation (Gajewski and Fitch, 1966) . However, based on in vivo anti-Listeria responses manifest in mice with T cellspecific IFNy unresponsiveness, we questioned whether IFNy played a physiologically important role in Th phenotype development. and HKLM plus anti-IL-12 (1:500 dilution polyclonal rabbit anti-IL-12). On day 7, the T cells were harvested, washed, counted, and restimulated at 2.5 x IO5 cells/well using 6 x lo8 SAL& splenocytes presenting 0.3 uM OVA peptide in the absence of experimental conditions. Supernatants were collected at 46 hr and cytokine profiles assayed by ELISA.
To explore this issue, we crossed the Ick-myc-mgRAIC transgenic mice to afi TCR transgenic mice expressing the DO1 1 .lO KJl-26'TCR.
T cells derived from DO1 1 .lO up TCR transgenic mice are naive clonally restricted CD4+ T cells specific for a peptide of ovalbumin (323-339) (Murphy et al., 1990) . The majority of the T cells derived from these doubly transgenic mice were CD4+, clonotype positive, phenotypically naive (i.e., MEL-14+), and expressed high levels of the epitope-tagged dominant-negative IFNy receptor a chain. On the basis of IFNy-dependent MHC class I enhancement, these cells were IFNy unresponsive. Clonotype-positive CD4+ T cells from the doubly transgenie mice were present in the periphery in amounts comparable to mice transgenic only for the DO1 1 .lO TCR.
ner that was indistinguishable from control TCR transgenie T cells. Neutralization of either IFNy or IL-12 during primary stimulation prevented HKLM-induced Thl development, as observed previously (Hsieh et al., 1993a (Hsieh et al., , 1993b . Addition of IL-4 to primary cultures induced Th2 development in both doubly transgenic T cells and control IFNy-responsive T cells. Neutralization of IL-4 during primary activation produced a Thl phenotype in both doubly transgeneic and control T cells. Thus, regulation of Th phenotype development in IFNy-unresponsive T cells is unaltered in comparison to that of IFNy-responsive T cells. These results demonstrate that IFNy is not required by these T cells for IL-12-induced Thl development.
IFNy Responsiveness by APCs Is Required for HKLM-Induced
Thl Development We examined Th development in these cells using an
The lack of role for T cell IFNy responsiveness suggested in vitro assay system. In this system, Thl and Th2 subsets that the APC may be the physiologic target of the actions are defined by the polarized production of IFNy but not of IFNy during Th phenotype development. Because of interleukin 4 (IL-4) and of IL-4 but not IFNy, respectively.
limited expression of the dominant-negative transgene in Purified T cells from T cell-targeted IFNy-unresponsive splenic macrophages, we were unable to use APC derived doubly transgenic mice or control mice expressing only from the macrophage-targeted mice. To circumvent this the DO1 1 .lO transgenes were activated in vitro with OVA problem, we took advantage of the observation that peptide and irradiated BALBlc splenocytes and allowed DO1 1 .lO transgenic T cells respond to OVA peptide pretodevelopfor 7 days. Following restimulation with antigen, sented either by H-2 or H-2b splenocytes. In initial control doubly transgenic T cells showed no substantial differexperiments, we determined that under avariety of culture ences in IL-4 or IFNy production compared with control conditions there were no significant differences in prolifer-DO1 1 .lO transgenic T cells (Figure 6 , top bars). IL-1 2 ination or cytokine production using either BALBlc (H-9 or duced Thl development of doubly transgenic T cells lack-129 Sv (H-2q splenocytes as the APCs (data not shown). ing IFNy responsiveness in a manner similar to that obWe then examined whether IFNy-unresponsive APC deserved with control TCR transgenic T cells. Furthermore, rived from spleens of 129s~ mice homozygous for the IFNy-unresponsive T cells expressed a Thl cytokine protargeted disruption of the IFNy receptor a chain (Huang et file when differentiated in the presence of HKLM in a manal., 1993) could effect normal Th phenotype development. DO1l.10 transgenic T cells were activated in vitro with OVA peptide and irradiated splenocytes derived from wildtype 129 Sv mice or 129 Sv mice lacking the IFNy receptor (TRKO). After incubation for 7 days, the Tcells were restimulated with OVA peptide and irradiated wild-type 129 Sv splenocytes. No substantial differences in IL-4 or IFNy production were observed between T cells primed using either control 129 Sv splenocytes or gRK0 splenocytes (Figure 7) . Thus, the lack of APC IFNy responsiveness produced no significant differences in the default development of TCR transgenic T cells.
In contrast, HKLM-induced Thl development required IFNy-responsive APCs. DO1 1 .lO transgenic T cells activated with HKLM and control 129 Sv splenocytes developed a strong Thl phenotype, as evidenced by the high levels of IFNy produced upon restimulation (Figure 7) . In contrast, HKLM-induced Thl development was nearly abrogated when yRK0 splenocytes were used as APCs during the primary stimulation. Neutralization of IFNy or IL-12 inhibited HKLM-induced Thl development as described (Hsieh et al., 1993a (Hsieh et al., , 1993b or hLP-myc-mgRAIC transgenic mice were stimulated with media or rMulFNv (1000 IRUlml) for 1 hr. PECs were then washed three times with media and HKLM (1 x 107/ml) was added. Supernatants were harvested 48 hr following HKLM addition and IL-12 production quantitated by IL-12 p40 ELISA (Tripp et al., 1994) .
PECs that were cultured in the absence or presence of IFNy. HKLM induced production of 0.95 rig/ml of IL-12 p40 in untreated 129 Sv PEC (Figure 8, top) . In contrast, HKLM induced 13 times more IL-12 p40 in IFNy-treated PECs (12.3 nglml of IL-12 ~40). The enhancement of HKLMinduced IL-12 production specifically required the presence of IFNy, since IFNa had no potentiating effects (data not shown). IFNy failed to enhance HKLM-induced IL-12 production in PEC derived from mice lacking the IFNy receptor (yRK0, Figure 8 , top). In addition, IFNy failed to enhance HKLM-induced IL-12 production in PEC derived from the hLP-myc-mgRAIC transgenic mice with macrophage-specific IFNy unre.sponsiveness (Figure 8, bottom) . Thus, we propose that IFNy acts to augment macrophage production of IL-12 and that this effect explains the obsewed requirement of IFNy forTh1 phenotype development.
Discussion
In this study, we demonstrate the generation of transgenic mice that express a dominant-negative IFNy receptor a chain mutant under the control of tissue-specific promoters and document that these mice exhibit tissue-specific unresponsiveness to IFNy. Using these mice, we identify the primary cellular targets of IFNy action in the welldefined models of murine Listeriosis and the MLR. Moreover, we establish a role for IFNy in influencing CD4+ Th subset development. These studies thus represent a novel method to define the cell-or tissue-specific actions of an endogenously produced pleiotropic cytokine in vivo.
Many cytokines such as IFNy, IL-6, and tumor necrosis factor (TNF) induce their pleiotropic effects on a wide variety of target cells due to the nearly ubiquitous expression of their respective cellular receptors. The widespread expression of certain cytokine receptors in vivo is a major obstacle preventing the definition of the cell-specific physiologic roles of these cytokines. However, recent studies have begun to define the structure-function relationships of many cytokine receptors, including those for IFNy, IL-6, and TNF, and this information can be used to develop novel methodologies to study the functions of specific cytokines in vivo. In the case of the IFNy receptor, it is now known that at least two receptor subunits are required for IFNy signaling: the IFNy receptor a chain, which is required for ligand binding, ligand trafficking, and signal transduction, and the IFNy receptor 6 chain, which is required primarily for signal transduction (Farrar and Schreiber, 1993) . Moreover, the functionally important sequences within the intracellulardomainsof the IFNy receptor a and 6 chains and the molecular interactions that effect initiation of the signal transduction cascade have been identified (Farraret al., 1991 (Farraret al., ,1992 Cooket al., 1992; Greenlund et al., 1994 Greenlund et al., , 1995 .
In the course of our structure-function studies of the IFNy receptor a chain, we observed that functionally inactive IFNy receptor a chain intracellular domain mutants, when overexpressed in homologous cells, functioned to inhibit cellular responses to ligand in a dominant-negative manner both in vitro (Dighe et al., 1993) and in vivo (Dighe et al., 1994) . The observations suggested that it might be possible to target IFNy unresponsiveness to specific tissues by generating transgenic mice that utilize tissuespecific promoters to direct expression of the dominantnegative receptor. Forthis purpose, we used acytoplasmitally truncated mutant IFNy receptor a chain, since we had previously established that it was unable to traffic efficiently through the cell and accumulated at high levels on the plasma membrane (Dighe et al., 1993) . To facilitate analysis of transgene expression, we used an epitopetagged form of the mutant polypeptide. This epitope tag did not effect the ability of the mutant receptor to bind ligand or interact with the receptor 6 chain.
The experiments presented herein demonstrate the validity of this approach using two different cellular targets. The human lysozyme promoter was used to direct expression of the dominant-negative IFNy receptor to the macrophage compartment and the Ick proximal promoter was used for T cell-specific expression. This technique represents a novel approach for disrupting cellular responsiveness to a cytokine ligand in a tissue-specific manner. One advantage of this system is that it can accommodate promoters that drive transgene expression to a low degree in cell types other than those that have been targeted. Induction of unresponsiveness to ligand occurs only in cells expressing high levels of the dominant-negative receptor mutant. In the case of the IFNy receptor a chain dominant-negative mutant, an approximately 1OO:l ratio of mutant to endogenous receptor is required for induction of IFNy unresponsiveness (Dighe et al., 1993) . Therefore, low level expression of mutant receptors in nontargeted cell types will be functionally silent. This protocol may be generalizable to a variety of different receptor systems, especially systems in which functionally active receptors are composed of at least two subunits.
The mice generated in our study have been useful in defining the physiologic cellular targets of the actions of IFNy in three different models. First, although macrophages have been assumed to be a critical target of IFNy action in anti-Listeria responses, this concept has never been formally tested. The results reported here unequivocally demonstrate this concept in vivo. Moreover, owing to the specific targeting of IFNy unresponsiveness to resident macrophages, thisstudy reveals the novel role played by these cells in initiating anti-Listeria responses.
The pattern of expression observed in the human lysozyme promoter transgenics in this study differs in some respects from that observed in another study (S. C., D. Ft. G., L.-P. Chung and S. G., unpublished data), in which transgenic mice were generated using the human lysozyme promoter fragment placed upstream of a bacterial chloramphenicol acetyltransferase (CAT) reporter gene. In these animals, CAT enzyme activity was detected in both thioglycollate-elicited macrophages and in cultured, but not freshly isolated, resident peritoneal macrophages, resembling the expression pattern of the endogenous murine lysozyme gene (Keshav et al., 1991) . The human lysozyme promoter also directed CAT expression in peritoneal thioglycollate-elicited PMN. In the transgenic mice analyzed in the current study, the human lysozyme promoter did not direct expression of the truncated IFNy receptor a chain to circulating PMN in normal uninfected mice. It is possible that the differences in expression patterns seen in these two studies reflect the different reporter genes and 3' untranslated regions present in the two constructs.
Second, we have defined the role of IFNy in regulating the MLR. Previous studies showed that proliferation of T cells during a MLR was suppressed as a result of IFNy production in the culture (Bucy et al., 1966; Huang et al., 1993; Dalton et al., 1993) . However, since MLR cultures contain multiple functionally important cell types, these earlier studies did not identify the cellular target(s) of IFNy action. In the current report, we show that the effects of IFNy are directed at the T cell. These results suggest that IFNy may play an important regulatory role during CD6+ T cell generation. We speculate that this action of IFNy may serve to prevent CD6+ T cell responses from causing immunopathologic reactions. Mice that specifically lack T cell IFNy responsiveness may be useful to examine the potential autoregulatory action of IFNy during CD8+-dependent antiviral or antitumor responses.
Finally, the mice generated in the current study have been used to elucidate a role for IFNy in CD4' Th cell phenotype development. IFNy is necessary for efficient Thl development (Hsieh et al., 1992 (Hsieh et al., , 1993a (Hsieh et al., , 1993b , and was suggested to regulate the development of Th2 responses by exerting an antiproliferative action specifically on Th2 cells (Gajewski and Fitch, 1988) . This concept has been supported by studies of experimental murine Leishmaniasis. Neutralization of IFNy using either neutralizing anti-IFNy MAbs (Scott, 1991) or targeted disruption of the IFNy gene (Wang et al., 1994) leads to an exacerbating disease in normally resistant mice. In contrast, administration of IFNy in vivo fails to cure susceptible BALBlc mice (Scott, 1991) . Therefore, IFNy appears to be necessary but not sufficient for the development of Thl ceils both in vitro and in vivo. However, because of the ubiquitous cellular expression of IFNy receptors, these studies were unable todefine the cellularsiteof IFNy action under physiologic circumstances.
In this report, we demonstrate that T cells made unresponsive to IFNy by the targeted specific in vivo expression of dominant-negative IFNy receptors maintain the capacity to differentiate towards both the Thl and Th2 phenotypes. The in vitro development of Thl cells induced by IL-12 or HKLM remains intact regardless of whether these T cells can respond to IFNy. These results are supported by the demonstration that mice with T cell-targeted IFNy unresponsiveness had no defect in their ability to develop sterilizing immunity to infection by Listeria monocytogenes, a process known to require intact Thl responses.
Previous work demonstrated that IFNy is necessary, but not sufficient, for HKLM-induced Thl development (Hsieh et al., 1993b) . The actions of pathogens such as Listeria for promoting Thl development are macrophage dependent, and rely on the production of IL-12 (Hsieh et al., 1993a , 1993b (Basel, Switzerland) . Hamster MAb specific for murine IFNy (H22) was produced and purified as described (Schreiber et al., 1985) . The anti-myc 9ElO MAb (Eva" et al., 1985) was conjugated to biotin using the EN20 biotinylating reagent (ENZO Biochemicals) as described (Sheehan et al., 1988) . The IL4specific
MAb 1 lBl1 (Ohara and Paul, 1985) has been previously described.
Fluorescein isothiocyanate (FITC)-or phy coerythrin (PE)-conjugated anti-murine H-2Kd, anti-murine H-2Kb. anti-CD3, anti-CD4, anti-B220, anti-Gr-1, and anti-NK cell (derived from clone 5E6) were purchased from Pharmingen (San Diego, California). F4/80 is an antigen specifcfor cells of the macrophage lineage (Austyn and Gordon, 1981) . FITC-conjugated anti-murine F4/80 MAb was purchased from Caltag. Hamster MAbs specific for ~35 (Red-T) and p40 (TOSH) subunits of IL-12 were provided by Drs. E. Unanue and C. Tripp (St. Louis, Missouri) (Tripp et al., 1994 Plasmid Construction Plasmids were constructed using standard procedures (Sambrook et al., 1989) . We previously generated and characterized a cDNA encoding a cytoplasmically truncated form of the murine IFNy receptor a chain, which contains only three intracellular domain amino acids (Dighe et al., 1993) . The truncated murine IFNy receptor mutant cDNA was subcloned into the pBSSKII (-) vector (Stratagene) and modified at its 5' end by insertion of nucleotides that encode 13 residues of c-myc (SMEQKLISEEDLN), against which the QElO MAb is directed (Eva" et al., 1985) . The myc sequences were inserted into the receptor such that they followed the signal sequence of the reeptor and first seven N-terminal amino acids to create a plasmid encoding the myctagged truncated murine IFNy receptor a chain (pBS.myc-mgRAIC). To ensure the myc tag did not interfere with the expression or the dominant-negative function of the truncated murine IFNy receptor, the myc-mgRAIC cDNA was subcloned into the pSFFV eukaryotic expression vector (Farrar et al., 1991) and stably transfected into murine L929 fibroblast cells to create the L929.myc-mgRAIC cell line. This cell line expressed high levels of the myc-tagged truncated receptor as assessed by flow cytometry, using either the 9ElO MAb or the anti-murine IFNr receptor MAb GR-20. As expected, the transfected cells were completely unresponsive lo murine IFNy but maintained responsiveness to IFNa. The ~1017 vector used for transgenic expression in the T cell compartment consists of the 3.2 kb Ick proximal promoter, which has been demonstrated to direct the expression of cDNAs to the thymocyte compartment (Cooke etal., 1991) . The transgenicconstruct wasgenerated by subcloning the myc-tagged truncated murine IFNy receptor cDNA into the BamHl site of the plU7vectortocreateplOl7,myc-mgRAIC.
To generate the fragment used for microinjection, pl017,mycmgRAIC was digested with Not1 and the 6.3 kb transgenic fragment isolated and purified by standard protocols (Cooke el al., 1991) .
The 3.5 kb human lysozyme promoter fragment has been demonstrated to direct expression of genes to the macrophage compartment (S. C., D. R. G., L.-P. Chung, and S. G., personal communication). The 2.1 kb BamHI-Not1 fragment (containing the human growth hormone gene) of ~1017 (Cooke et al., 1991) was subcloned into the BamHl and Not1 sites of pBSSKII (-) to create pBS.hGH. The 3.5 kb KpnlHincll human lysozyme promoter fragment from pUClS.hLP was then subcloned into the Kpnl and Hincll sites of pBS.hGH to create pBS.hLP-hGH.
The myc-lagged truncated murine IFNy receptor cDNA was then subcloned into the BamHl site of this plasmid to create pBS.hLP-myc-mgR-hGH.
To generate the microinjected fragment, pBS.hLP-myc-mgRAIC-hGH was digested with Kpnl and Not I and the 6.6 kb transgenic fragment was isolated and purified. and allowed to adhere for 2 hr. Adherent PECs were then washed three times with warmed media. PECs were stimulated with either LPS (10 pglml), rMulFNy(1000IRU/ml),orrHulFNa~~(1000IRU/ml),orvariouscombinations of the above reagents at the same concentration.
After 48 hr of stimulation, supernatants were harvested and the level of nitrite determined by the Greiss reaction (Green et al., 1982) . IL-12 production by PEC was performed essentially as previously described (Tripp et al., 1993) . PEC (5 x 105) were seeded in a Costar 24-well tissue culture plate and allowed to adhere for 2 hr. Adherent PECs were washed three times with warmed media and were then stimulated with rMulFNy (1000 IRUlml) or rHulFNaA.o (1000 IRUlml) for 1 hr. PECs were then washed three times with warmed media and HKLM (1 x 10'1 ml) was added. Supernatants were harvested 48 hr following HKLM addition and IL-1 2 production was quantitated using a SCID splenocyte bioassay (Ishida et al., 1992) and by capture ELISA for the IL-12 p40 subunit (Tripp et al., 1994) . Listeria Viable and heat-killed Listeria monocytogenes was provided by Dr. E. Unanue (St. Louis, Missouri). Listeria was diluted in saline and injected intraperitoneally at an infecting dose of 5 x lo5 cfu in 0.4 ml. Bacteria in the spleens and livers of infected mice were quantitated by colony counts of homogenates in PBS with 0.05% Triton X-l 00 plated on BHI agar. MLR MLR were carried out by culturing 5 x 1 O5 responder H-2d splenocytes with irradiated (2000 rads) C57BU6 (H-2b) splenocytes (stimulator cells) in a 96-well plate. Proliferation was assessed by thymidine incorporation (Rogers et al., 1992) . IFNy was neutralized by addition of 100 pglml of anti-IFNy MAb H22 to the culture.
Transgenic
T Cell Purification CD4+ T cells were purified by FACS sorting with FITC-conjugated anti-CD4 and PEconjugated Mel-l 4 (Pharmingen) as previously described (Hsieh et al., 1995) . Sorted T cells were routinely >98% CD4+/Mel-14+.
T Cell Culture T cells were cultured in Iscove's complete media as previously described (Hsieh et al., 1992) . T cells (2.5 x 1OYwell) were stimulated in the presence of added cytokines or anti-cytokine antibodies in 24-well plates with 0.3 pM OVA peptide presented by 6 x 10 splenocyes derived from BALB/c, 129 Sv, or yRK0 mice (Dalton et al., 1993) . Recombinant murine IL-4(Genzyme, Cambridge, Massachusetts) was used at 20 U/ml. was used at 5 U/ml. The anti-IL-4 MAb 11511 and anti-IFNy MAb H22 were used at 10 @ml. Rabbit anti-murine IL-12 polyclonal antisera (Hoffman-LaRoche) was used at a 1500 dilution. Heat-killed Listeria monocytogenes was used at 1 x 1 O'lml. On day 7. the T cells were harvested, washed, counted. and restimulated at 2.5 x lo5 cells/wefl by 6 x 1Q splenocytes presenting 0.3 PM OVA peptide in the absence of experimental conditions to determine the resulting Th cell phenotype.
Supernatants were collected at 48 hr and cytokine profiles assayed by ELISA.
Cytokine
Assays Quantitation of IL-4 and IFNy were quantitated by ELISA as previously described (Hsieh et al., 1992) . Standard curves were generated using recombinant cytokines from Genzyme.
